PushMe

Auto-generated event page

MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock

Financing included participation by healthcare-dedicated investors alongside existing shareholders

Score 41 low confidence 1 source posts Updated Mar 4, 2026, 9:06 PM UTC